Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ACCD - Accolade Inc


IEX Last Trade
4.335
0.025   0.577%

Share volume: 1,864,167
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$4.31
0.03
0.58%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-1.81%
1 Month
4.83%
3 Months
-39.39%
6 Months
-58.63%
1 Year
-68.14%
2 Year
-57.07%
Key data
Stock price
$4.34
P/E Ratio 
-3.90
DAY RANGE
N/A - N/A
EPS 
-$1.17
52 WEEK RANGE
$3.35 - $15.36
52 WEEK CHANGE
-$0.68
MARKET CAP 
347.236 M
YIELD 
N/A
SHARES OUTSTANDING 
80.008 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/02/2024
BETA 
2.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$749,125
AVERAGE 30 VOLUME 
$974,013
Company detail
CEO:
Region: US
Website: accolade.com
Employees: 970
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. with a unique blend of compassionate advisors, clinical experts and intelligent technologies, we engage individuals and families in their health, establish trust, and influence their decisions at every stage of care. we’ve been recognized as one of the nation’s 25 most promising companies by forbes magazine, the fastest-growing private healthcare company by inc. 500, and a top workplace by multiple news publications. for more information, visit www.accolade.com.

Recent news